Imperfect vaccine-induced immunity and whooping cough transmission to infants

Vaccine

Volumn 29, Issue 1, 2010, Pages 11-16

  Lavine, Jennie ^a   Broutin, Hélène ^b,c   Harvill, Eric T ^a   Bjørnstad, Ottar N ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c University de Montpellier   (France)

Author keywords

Bordetella; Immunity; Transmission

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CHILD; DISEASE DURATION; DISEASE TRANSMISSION; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NEWBORN; NONHUMAN; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MASSACHUSETTS; PERTUSSIS VACCINE; VACCINATION; WAVELET ANALYSIS; WHOOPING COUGH; YOUNG ADULT;

EID: 78649692659     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.029     Document Type: Article

References (38)

1. Cherry J.D. The science and fiction of the "resurgence" of pertussis. Pediatrics 2003, 112(2):405-406.
2. Yih W.K., Lett S.M., des Vignes F.N., Garrison K.M., Sipe P.L., Marchant C.D. The increasing incidence of pertussis in massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000, 182(5):1409-1416.
3. Skowronski D.M., De Serres G., MacDonald D., Wu W., Shaw C., Macnabb J. The changing age and seasonal profile of pertussis in canada. J Infect Dis 2002, 185(10):1448-1453.
4. Bisgard K.M., Pascual F.B., Ehresmann K.R., Miller C.A., Cianfrini C., Jennings C.E. Infant pertussis: who was the source?. Pediatr Infect Dis J 2004, 23(11):985-989.
5. Deen J.L., Mink C.A., Cherry J.D., Christenson P.D., Pineda E.F., Lewis K. Household contact study of bordetella pertussis infections. Clin Infect Dis 1995, 21(5):1211-1219.
6. Wirsing von König C.H., Postels-Multani S., Bock H.L., Schmitt H.J. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995, 346(8986):1326-1329.
7. C. for Disease Control, C. Prevention, Pertussis-United states, 2001-2003. MMWR Morb Mortal Wkly Rep 54 (50) (2005) 1283-1286.
8. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005, 24(5 Suppl.):S58-S61.
9. Strebel P., Nordin J., Edwards K., Hunt J., Besser J., Burns S. Population-based incidence of pertussis among adolescents and adults, minnesota, 1995-1996. J Infect Dis 2001, 183(9):1353-1359.
10. Cherry J.D. Pertussis vaccines for adolescents and adults. Pediatrics 2005, 116(3):755-756.
11. Watanabe M., Nagai M. Whooping cough due to bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2004, 2(June 3):447-454.
12. Massachusetts Department of Public Health, 617-983-6800. Pertussis Advisory (March 2004).
13. Mazengia E., Silva E.A., Peppe J.A., Timperi R., George H. Recovery of bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains. J Clin Microbiol 2000, 38(6):2330-2333.
14. Hastie T., Tibshirani R., Friedman J.H. The elements of statistical learning: data mining, inference, and prediction: with 200 full-color illustrations 2001, Springer, New York, http://www.loc.gov/catdir/enhancements/fy0813/2001031433-d.html.
15. Grenfell B.T., Bjornstad O.N., Kappey J. Travelling waves and spatial hierarchies in measles epidemics. Nature 2001, 414(December 6865):716-723.
16. Bloomfield P. Fourier analysis of time series: an introduction, 2nd Edition, Wiley series in probability and statistics. Applied probability and statistics section 2000, Wiley, New York, http://www.loc.gov/catdir/bios/wiley042/99057531.html.
17. Faraway J.J. Extending the linear model with R: generalized linear, mixed effects and nonparametric regression models, Chapman and Hall/CRC texts in statistical science series 2006, Chapman and Hall/CRC, Boca Raton, http://www.loc.gov/catdir/enhancements/fy0646/2005054822-d.html.
18. R Development Core Team R: A Language and environment for statistical computing 2007, R Foundation for Statistical Computing, Vienna, Austria, ISBN: 3-900051-07-0. http://www.R-project.org.
19. Broutin H., Guegan J-F., Elguero E., Simondon F., Cazelles B. Large-scale comparative analysis of pertussis population dynamics: periodicity, synchrony, and impact of vaccination. Am J Epidemiol 2005, 161(12):1159-1167.
20. Pebody R.G., Gay N.J., Giammanco A., Baron S., Schellekens J., Tischer A. The seroepidemiology of bordetella pertussis infection in western europe. Epidemiol Infect 2005, 133(1):159-171.
21. Broutin H., Simondon F., Rohani P., Guegan J-F., Grenfell B. Loss of immunity to pertussis in a rural community in senegal. Vaccine 2004, 22:594-596.
22. De Greeff S., Dekkers A., Teunis P., Rahamat-Langendoen J., Mooi F., De Melker H. Seasonal patterns in time series of pertussis. Epidemiol Infect 2009, 1-8. 10.1017/S0950268809002489.
23. Cherry J.D. Pertussis in adults. Ann Intern Med 1998, 128(January 1):64-66.
24. Luttinger P. The epidemiology of pertussis. Am J Dis Child 1916, 12:290-315.
25. Versteegh F.G.A., Schellekens J.F.P., Nagelkerke A.F., Roord J.J. Laboratory-confirmed reinfections with bordetella pertussis. Acta Paediatr 2002, 91(1):95-97.
26. Mooi F.R., van Loo I.H.M., van Gent M., He Q., Bart M.J., Heuvelman K.J. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009, 15(8):1206-1213.
27. Lautrop H. Epidemics of parapertussis: 20 years' observations in denmark. The Lancet 1971, 1(7711):1195-1198.
28. Watanabe M., Nagai M. Reciprocal protective immunity against bordetella pertussis and bordetella parapertussis in a murine model of respiratory infection. Infect Immun 2001, 69(11):6981-6986.
29. Wolfe D.N., Goebel E.M., Bjornstad O.N., Restif O., Harvill E.T. The o antigen enables bordetella parapertussis to avoid bordetella pertussis-induced immunity. Infect Immun 2007, 75(10):4972-4979.
30. David S., van Furth R., Mooi F.R. Efficacies of whole cell and acellular pertussis vaccines against bordetella parapertussis in a mouse model. Vaccine 2004, 22(15-16):1892-1898.
31. Heininger U., Stehr K., Christenson P., Cherry J.D. Evidence of efficacy of the lederle/takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against bordetella parapertussis infection. Clin Infect Dis 1999, 28(3):602-604.
32. Willems R.J., Kamerbeek J., Geuijen C.A., Top J., Gielen H., Gaastra W. The efficacy of a whole cell pertussis vaccine and fimbriae against bordetella pertussis and bordetella parapertussis infections in a respiratory mouse model. Vaccine 1998, 16(February 4):410-416.
33. Liese J.G., Renner C., Stojanov S., Belohradsky B.H. Clinical and epidemiological picture of b pertussis and b parapertussis infections after introduction of acellular pertussis vaccines. Arch Dis Child 2003, 88(August 8):684-687.
34. Khelef N., Danve B., Quentin-Millet M.J., Guiso N. Bordetella pertussis and bordetella parapertussis: two immunologically distinct species. Infect Immun 1993, 61(2):486-490.
35. Gordon J.E., Hood R.I. Whooping cough and its epidemiological anomalies. Am J Med Sci 1951, 222(3):333-361.
36. Halperin S.A. The control of pertussis-2007 and beyond. N Engl J Med 2007, 356(January 2):110-113.
37. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E. Changing epidemiology of pertussis in the united states: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999, 28(6):1230-1237.
38. Long G.H., Karanikas A.T., Harvill E.T., Read A.F., Hudson P.J. Acellular pertussis vaccination facilitates bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci 2010, 277(1690):2017-2025.